Literature DB >> 19121607

Analysis of in vitro lymphocyte proliferation as a screening tool for cellular immunodeficiency.

Kelly D Stone1, Henry A Feldman, Charlotte Huisman, Cathryn Howlett, Haifa H Jabara, Francisco A Bonilla.   

Abstract

Measuring lymphocyte response to mitogens and antigens is a mainstay of screening for cellular immunodeficiency. Few reports analyze performance as a screening tool in diverse patient cohorts. We studied proliferation assays performed at Children's Hospital Boston from 1996 to 2003 using mitogens phytohemagglutinin (PHA), concanavalin A (CONA) and pokeweed mitogen, and antigens tetanus (TT) and diphtheria (DT) toxoids, and compared a subset of patients with T cell dysfunction with adult controls using receiver operating characteristic analysis. Results were correlated with clinical data. CONA was superior to PHA in identifying patients with immunodeficiency. TT was second best. Interpretation based on raw CPM, a stimulation index, or reference to simultaneous controls all performed equally. Combining data from multiple mitogens and/or antigens did not enhance performance. Proliferation testing is a useful component of screening for cellular immunodeficiency, but is not a sensitive predictor of cellular immune compromise or risk of opportunistic infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19121607     DOI: 10.1016/j.clim.2008.11.003

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  16 in total

1.  In vitro T lymphocyte proliferation by carboxyfluorescein diacetate succinimidyl ester method is helpful in diagnosing and managing primary immunodeficiencies.

Authors:  Elif Azarsiz; Neslihan Karaca; Birgul Ergun; Mehmet Durmuscan; Necil Kutukculer; Guzide Aksu
Journal:  J Clin Lab Anal       Date:  2017-04-06       Impact factor: 2.352

2.  Assessment of human lymphocyte proliferation associated with metabolic syndrome.

Authors:  O A Pinzón; J C Sánchez; J C Sepúlveda-Arias; D F López-Zapata
Journal:  J Endocrinol Invest       Date:  2015-05-16       Impact factor: 4.256

3.  Normal response to vaccines in inflammatory bowel disease patients treated with thiopurines.

Authors:  Iris Dotan; Lael Werner; Sharon Vigodman; Shradha Agarwal; Jorge Pfeffer; Noya Horowitz; Lisa Malter; Maria Abreu; Thomas Ullman; Hanan Guzner-Gur; Zamir Halpern; Lloyd Mayer
Journal:  Inflamm Bowel Dis       Date:  2011-03-15       Impact factor: 5.325

4.  Comparison of mitogen-induced proliferation in child and adult healthy groups by flow cytometry revealed similarities.

Authors:  Zakya Shoub Elshari; Serdar Nepesov; Ilhan Tahrali; Ayca Kiykim; Yildiz Camcioglu; Gunnur Deniz; Umut Can Kucuksezer
Journal:  Immunol Res       Date:  2022-10-20       Impact factor: 4.505

5.  Versatility of using major histocompatibility complex class II dextramers for derivation and characterization of antigen-specific, autoreactive T cell hybridomas.

Authors:  Bharathi Krishnan; Chandirasegaran Massilamany; Rakesh H Basavalingappa; Rajkumar A Rajasekaran; Charles Kuszynski; Barbara Switzer; Daniel A Peterson; Jay Reddy
Journal:  J Immunol Methods       Date:  2015-08-09       Impact factor: 2.303

6.  Immunologic recovery in children after alternative donor allogeneic transplantation for hematologic malignancies: comparison of recipients of partially T cell-depleted peripheral blood stem cells and umbilical cord blood.

Authors:  Benjamin R Oshrine; Yimei Li; David T Teachey; Jennifer Heimall; David M Barrett; Nancy Bunin
Journal:  Biol Blood Marrow Transplant       Date:  2013-08-11       Impact factor: 5.742

7.  A homozygous mucosa-associated lymphoid tissue 1 (MALT1) mutation in a family with combined immunodeficiency.

Authors:  Haifa H Jabara; Toshiro Ohsumi; Janet Chou; Michel J Massaad; Halli Benson; Andre Megarbane; Eliane Chouery; Raymond Mikhael; Oliver Gorka; Andreas Gewies; Pierre Portales; Toshinori Nakayama; Hiroyuki Hosokawa; Patrick Revy; Henry Herrod; Francoise Le Deist; Gerard Lefranc; Jürgen Ruland; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2013-05-31       Impact factor: 10.793

8.  Reversible severe combined immunodeficiency phenotype secondary to a mutation of the proton-coupled folate transporter.

Authors:  Arturo Borzutzky; Brian Crompton; Anke K Bergmann; Silvia Giliani; Sachin Baxi; Madelena Martin; Ellis J Neufeld; Luigi D Notarangelo
Journal:  Clin Immunol       Date:  2009-09-09       Impact factor: 3.969

9.  Relevance of laboratory testing for the diagnosis of primary immunodeficiencies: a review of case-based examples of selected immunodeficiencies.

Authors:  Roshini S Abraham
Journal:  Clin Mol Allergy       Date:  2011-04-09

Review 10.  Predictors of shingles reports at diagnosis of common variable immunodeficiency and selective immunoglobulin G subclass deficiency in 212 Alabama adults.

Authors:  James C Barton; J Clayborn Barton; Luigi F Bertoli
Journal:  Infect Dis Rep       Date:  2012-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.